1. GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton
- Author
-
Annika Pfeiffer, Eva-Maria Hanschmannn, Jonas Schwirz, Sara Bitar, Ibrahim Boussaad, Oliver Brüstle, Kristina Dobrindt, Caterina Vianello, Diones Caeran Bueno, Michael Peitz, Alireza Pouya, Christina Wolf, Stefan Tenzer, Rejko Krüger, Marta Giacomello, Sandra Ritz, Federica Dal Bello, Axel Methner, and Sabine Arndt
- Subjects
Cytosol ,Chemistry ,Lipid droplet ,Mitochondrial pyruvate dehydrogenase complex ,Mitochondrion ,Pyruvate dehydrogenase complex ,Actin cytoskeleton ,Homeostasis ,Actin ,Cell biology - Abstract
Charcot-Marie-Tooth (CMT) disease 4A is an autosomal-recessive polyneuropathy caused by mutations of ganglioside-induced differentiation-associated protein 1 (GDAP1), a putative glutathione transferase, which affects mitochondrial shape and alters cellular calcium homeostasis. Here, we identify the underlying mechanism. We found that patient-derived motoneurons and GDAP1 knockdown SH-SY5Y cells display two phenotypes: more tubular mitochondria and a metabolism characterized by glutamine dependence and fewer cytosolic lipid droplets. GDAP1 interacts with the actin-depolymerizing protein Cofilin-1 in a redox-dependent manner, suggesting a role for actin signaling. Consistently, GDAP1 loss causes less F-actin close to mitochondria, which restricts mitochondrial localization of the fission factor dynamin-related protein 1, instigating tubularity. Changes in the actin cytoskeleton also disrupt mitochondria-ER contact sites. This results in lower mitochondrial calcium levels and inhibition of the pyruvate dehydrogenase complex, explaining the metabolic changes upon GDAP1 loss of function. Together, these findings reconcile GDAP1-associated phenotypes and implicate disrupted actin signaling in CMT4A pathophysiology.
- Published
- 2021
- Full Text
- View/download PDF